INS and Insulin resistance: By binding to GLP-1 receptors on β-cells, these agents potentiate glucose-dependent insulin secretion, improving first- and second-phase insulin responses during meals without driving hypoglycemia—an especially important consideration for children with preserved β-cell function or insulin resistance rather than absolute insulin deficiency [19,27,28].